Franklin Resources’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-80,973
Closed -$305K – 3185
2025
Q2
$305K Sell
80,973
-37,542
-32% -$148K ﹤0.01% 2554
2025
Q1
$537K Buy
118,515
+15,309
+15% +$81K ﹤0.01% 2238
2024
Q4
$730K Sell
103,206
-935
-0.9% -$7.45K ﹤0.01% 2128
2024
Q3
$857K Buy
104,141
+5,687
+6% +$41.1K ﹤0.01% 2052
2024
Q2
$629K Sell
98,454
-1,280
-1% -$8.22K ﹤0.01% 2131
2024
Q1
$751K Buy
99,734
+69,516
+230% +$635K ﹤0.01% 2075
2023
Q4
$280K Sell
30,218
-274
-0.9% -$2.24K ﹤0.01% 2211
2023
Q3
$309K Hold
30,492
– – ﹤0.01% 2143
2023
Q2
$381K Buy
+30,492
New +$363K ﹤0.01% 2102

Other funds holding HCAT

Franklin Resources's HCAT Position: Q3 2025 in Review

Franklin Resources sold out of Health Catalyst (HCAT) in Q3 2025, closing a stake of 80,973 shares — an estimated $305K sold.

Franklin Resources first reported a position in HCAT in Q2 2023 and held it in 9 quarters. The position peaked at $857K in Q3 2024. 145 funds tracked by Wall St. Rank hold HCAT as of Q3 2025.

  • Franklin Resources reported no remaining Health Catalyst position as of Q3 2025 after selling out during the quarter.
  • Franklin Resources sold 80,973 Health Catalyst shares in Q3 2025, an estimated $305K.
  • Franklin Resources first reported a position in Health Catalyst in Q2 2023 and held it in 9 quarters.
  • Franklin Resources's Health Catalyst position peaked at $857K in Q3 2024.
  • 145 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2025.

Based on Franklin Resources's 13F filing for Q3 2025, filed 13 Nov 2025.